Effective Dose to Immune Cells (EDIC) Predicts Event-free Survival in Triple-Negative Breast Cancer Treated With

P Loap1, C Fouillade2, L De Marzi2

  • 1Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Department of Radiation Oncology, Institut Curie, Paris, France; Advanced Therapy in Radiation Oncology and Molecular Imaging Characterisation (ATOMIC), Institut Curie, Orsay, France.

Clinical Oncology (Royal College of Radiologists (Great Britain))
|May 29, 2026
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos